168 related articles for article (PubMed ID: 26902039)
1. Multidisciplinary Approach in Hepatocellular Carcinoma in a Level II Hospital: The First Decade of Hospital Universitario Fundacion Alcorcon.
Loinaz Segurola C; LIedó Navarro JL; Burgos Rde L; Martín Ríos D; Ochando Cerdán F; Alonso López S; Martel Villagrán J; Gutiérrez Garcia ML; Fernandez Cebrián JM; Fernández Rodríguez C
Hepatogastroenterology; 2015 Jun; 62(140):971-7. PubMed ID: 26902039
[TBL] [Abstract][Full Text] [Related]
2. Liver tumors and loco-regional therapy.
Vogel W
Wien Med Wochenschr; 2013 Mar; 163(5-6):107-8. PubMed ID: 23456251
[No Abstract] [Full Text] [Related]
3. Practical Considerations of Real Life of Hepatocellular Carcinoma in a Tertiary Center of Brazil.
Almeida-Carvalho SR; Gomes-Ferraz ML; Loureiro-Matos CA; Benedito-Silva AT; Carvalho-Filho RJ; Renato-Perez R; Miziara-Gonzalez A; Salzedas-Netto AA; Szejnfeld D; D'Ippolito G; Pereira-Lanzoni V; Souza-Silva I
Ann Hepatol; 2017; 16(2):255-262. PubMed ID: 28233747
[TBL] [Abstract][Full Text] [Related]
4. Outcome of patients with hepatocellular carcinoma referred to a tertiary centre with availability of multiple treatment options including cadaveric liver transplantation.
Perry JF; Charlton B; Koorey DJ; Waugh RC; Gallagher PJ; Crawford MD; Verran DJ; McCaughan GW; Strasser SI
Liver Int; 2007 Nov; 27(9):1240-8. PubMed ID: 17919236
[TBL] [Abstract][Full Text] [Related]
5. JAMA PATIENT PAGE. Treatment of Liver Cancer.
Mokdad AA; Singal AG; Yopp AC
JAMA; 2016 Jan; 315(1):100. PubMed ID: 26746473
[No Abstract] [Full Text] [Related]
6. Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trial.
Bruix J; Raoul JL; Sherman M; Mazzaferro V; Bolondi L; Craxi A; Galle PR; Santoro A; Beaugrand M; Sangiovanni A; Porta C; Gerken G; Marrero JA; Nadel A; Shan M; Moscovici M; Voliotis D; Llovet JM
J Hepatol; 2012 Oct; 57(4):821-9. PubMed ID: 22727733
[TBL] [Abstract][Full Text] [Related]
7. Review article: the management of hepatocellular carcinoma.
Cabrera R; Nelson DR
Aliment Pharmacol Ther; 2010 Feb; 31(4):461-76. PubMed ID: 19925500
[TBL] [Abstract][Full Text] [Related]
8. [Resection or interventional treatment of hepatocellular carcinoma: which method for which patient?].
Lang H; Ricke J; Schlaak J
Dtsch Med Wochenschr; 2013 Sep; 138(36):1780-4. PubMed ID: 23943578
[No Abstract] [Full Text] [Related]
9. [Influence of treatment of hepatocellular carcinoma before liver transplantation on post transplant tumor recurrence and survival].
Díaz-Sánchez A; Matilla A; Núñez O; Merino B; Peligros I; Rincón D; Salcedo M; Lo Iacono O; Vega Catalina M; Clemente G; Bañares R
Gastroenterol Hepatol; 2010 Mar; 33(3):155-64. PubMed ID: 19945770
[TBL] [Abstract][Full Text] [Related]
10. Management of hepatocellular carcinoma: an overview of major findings from meta-analyses.
Qi X; Zhao Y; Li H; Guo X; Han G
Oncotarget; 2016 Jun; 7(23):34703-51. PubMed ID: 27167195
[TBL] [Abstract][Full Text] [Related]
11. Pattern of macrovascular invasion in hepatocellular carcinoma.
Guarino M; Cucchetti A; Pontillo G; Farinati F; Benevento F; Rapaccini GL; Di Marco M; Caturelli E; Zoli M; Rodolfo S; Cabibbo G; Marra F; Mega A; Gasbarrini A; Svegliati-Baroni G; Foschi FG; Missale G; Masotto A; Nardone G; Raimondo G; Azzaroli F; Vidili G; Oliveri F; Trevisani F; Giannini EG; Morisco F;
Eur J Clin Invest; 2021 Jul; 51(7):e13542. PubMed ID: 33755196
[TBL] [Abstract][Full Text] [Related]
12. Prospective evaluation of the management of hepatocellular carcinoma in the elderly.
Ozenne V; Bouattour M; Goutté N; Vullierme MP; Ripault MP; Castelnau C; Valla DC; Degos F; Farges O
Dig Liver Dis; 2011 Dec; 43(12):1001-5. PubMed ID: 21798829
[TBL] [Abstract][Full Text] [Related]
13. Recurrent hepatocellular carcinoma in liver transplant recipients: parameters affecting time to recurrence, treatment options and survival in the sorafenib era.
Pfiffer TE; Seehofer D; Nicolaou A; Neuhaus R; Riess H; Trappe RU
Tumori; 2011; 97(4):436-41. PubMed ID: 21989430
[TBL] [Abstract][Full Text] [Related]
14. Addition of local hepatic therapy to sorafenib in patients with advanced hepatocellular carcinoma (stage BCLC C).
Schmidt L; op den Winkel M; Fischer K; Straub G; Rauch B; Paprottka PM; Göke B; Kolligs FT
Digestion; 2014; 90(4):219-28. PubMed ID: 25502689
[TBL] [Abstract][Full Text] [Related]
15. Current management of hepatocellular carcinoma.
Mendizabal M; Reddy KR
Med Clin North Am; 2009 Jul; 93(4):885-900, viii. PubMed ID: 19577120
[TBL] [Abstract][Full Text] [Related]
16. Early intrahepatic recurrence of hepatocellular carcinoma after hepatectomy treated with re-hepatectomy, ablation or chemoembolization: a prospective cohort study.
Wang K; Liu G; Li J; Yan Z; Xia Y; Wan X; Ji Y; Lau WY; Wu M; Shen F
Eur J Surg Oncol; 2015 Feb; 41(2):236-42. PubMed ID: 25434327
[TBL] [Abstract][Full Text] [Related]
17. Real Life Treatment of Hepatocellular Carcinoma: Impact of Deviation from Guidelines for Recommended Therapy.
Alkhatib A; Gomaa A; Allam N; Rewisha E; Waked I
Asian Pac J Cancer Prev; 2015; 16(16):6929-34. PubMed ID: 26514470
[TBL] [Abstract][Full Text] [Related]
18. Management of hepatocellular carcinoma.
Del Pozo AC; López P
Clin Liver Dis; 2007 May; 11(2):305-21. PubMed ID: 17606209
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular Carcinoma Management in Nonalcoholic Fatty Liver Disease Patients: Applicability of the BCLC Staging System.
Kikuchi L; Oliveira CP; Alvares-da-Silva MR; Tani CM; Diniz MA; Stefano JT; Chagas AL; Alencar RS; Vezozzo DC; Santos GR; Campos PB; Alves VA; Ratziu V; Carrilho FJ
Am J Clin Oncol; 2016 Oct; 39(5):428-32. PubMed ID: 25268068
[TBL] [Abstract][Full Text] [Related]
20. [Multimodality treatment for hepatocellular carcinoma].
Malek NP; Vogel A; Manns MP
Internist (Berl); 2010 Nov; 51(11):1374-81. PubMed ID: 20938626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
